Autism and Epilepsy: New Study Findings, 6 Facts and Real-Life Experience
Children with epilepsy have a fifth higher risk of having autism spectrum disorder (ASD), a new study says. Learn more.
Dodgers Star Freddie Freeman Grants Dream Day for Teen Living with Epilepsy
Dodgers star Freddie Freeman made a teen’s dream come true with a memorable visit to Dodger Stadium. Read more.
How Climate Change May Impact Certain Types of Epilepsy
As climate change brings more intense heat waves, new research suggests rising temperatures may especially affect people with rare genetic conditions, including some epilepsies. Learn more.
Examining Evidence Gaps and Ketogenic Diet in Epilepsy Care
Despite its effectiveness in drug-resistant epilepsy, gaps in evidence, access, and long-term use continue to limit the ketogenic diet’s role in care. Learn more.
Young Innovators Have Created a ‘Fitbit’ to Predict Epileptic Seizures
Young innovators are developing a wearable “Fitbit-like” device that uses brain activity data to predict epileptic seizures in advance and alert patients and caregivers. Read more.
Survey Highlights Gaps in Epilepsy Treatment Expectations and Communication
This survey highlights gaps between patients and clinicians in epilepsy care, including differences in treatment expectations and communication barriers. Learn more.
Patient-Centered Care Helps Ease the Challenges of Epilepsy
A patient-centered, team-based approach to epilepsy care may improve seizure control and quality of life by tailoring treatment to each individual. Learn more.
Poor Sleep May Raise Dementia Risk in People with Epilepsy
This study links optimal sleep to better cognition and lower dementia risk in people with focal epilepsy, highlighting sleep as a key factor in long-term brain health. Learn more.
TV Storylines Spotlight Ongoing Stigma and Misconceptions Around Epilepsy
Recent TV storylines highlight key realities of epilepsy, including stigma, first aid misconceptions, and driving challenges. Learn more.
New Phase III Data Strengthens Case for Azetukalner in Focal Epilepsy
Xenon Pharmaceuticals reported positive Phase III results for Azetukalner at the American Academy of Neurology annual meeting, potentially shifting focal epilepsy treatment. Learn more.